866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Small Molecule Active Pharmaceutical Ingredient Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 123 Pages

In this report, the EMEA Small Molecule Active Pharmaceutical Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Small Molecule Active Pharmaceutical Ingredient for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Small Molecule Active Pharmaceutical Ingredient market competition by top manufacturers/players, with Small Molecule Active Pharmaceutical Ingredient sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co, Inc.
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation?
GILEAD Science Inc.

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Standard API
High Potency API

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Small Molecule Active Pharmaceutical Ingredient for each application, including
Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Small Molecule Active Pharmaceutical Ingredient Market Report 2017
1 Small Molecule Active Pharmaceutical Ingredient Overview
1.1 Product Overview and Scope of Small Molecule Active Pharmaceutical Ingredient
1.2 Classification of Small Molecule Active Pharmaceutical Ingredient
1.2.1 EMEA Small Molecule Active Pharmaceutical Ingredient Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Small Molecule Active Pharmaceutical Ingredient Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Standard API
1.2.4 High Potency API
1.3 EMEA Small Molecule Active Pharmaceutical Ingredient Market by Application/End Users
1.3.1 EMEA Small Molecule Active Pharmaceutical Ingredient Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Cardiovascular Diseases
1.3.3 Respiratory Disorders
1.3.4 Infectious Diseases
1.3.5 Others
1.4 EMEA Small Molecule Active Pharmaceutical Ingredient Market by Region
1.4.1 EMEA Small Molecule Active Pharmaceutical Ingredient Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Small Molecule Active Pharmaceutical Ingredient (2012-2022)
1.5.1 EMEA Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2022)
1.5.2 EMEA Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2022)

2 EMEA Small Molecule Active Pharmaceutical Ingredient Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Small Molecule Active Pharmaceutical Ingredient Market Competition by Players/Manufacturers
2.1.1 EMEA Small Molecule Active Pharmaceutical Ingredient Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Small Molecule Active Pharmaceutical Ingredient Revenue and Share by Players (2012-2017)
2.1.3 EMEA Small Molecule Active Pharmaceutical Ingredient Sale Price by Players (2012-2017)
2.2 EMEA Small Molecule Active Pharmaceutical Ingredient (Volume and Value) by Type/Product Category
2.2.1 EMEA Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Small Molecule Active Pharmaceutical Ingredient Sale Price by Type (2012-2017)
2.3 EMEA Small Molecule Active Pharmaceutical Ingredient (Volume) by Application
2.4 EMEA Small Molecule Active Pharmaceutical Ingredient (Volume and Value) by Region
2.4.1 EMEA Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Small Molecule Active Pharmaceutical Ingredient Sales Price by Region (2012-2017)

3 Europe Small Molecule Active Pharmaceutical Ingredient (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales and Value (2012-2017)
3.1.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
3.2 Europe Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Type
3.3 Europe Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Application
3.4 Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume by Countries (2012-2017)
3.4.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2012-2017)
3.4.3 Germany Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
3.4.4 France Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
3.4.5 UK Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
3.4.6 Russia Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
3.4.7 Italy Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
3.4.8 Benelux Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)

4 Middle East Small Molecule Active Pharmaceutical Ingredient (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Small Molecule Active Pharmaceutical Ingredient Sales and Value (2012-2017)
4.1.1 Middle East Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
4.2 Middle East Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Type
4.3 Middle East Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Application
4.4 Middle East Small Molecule Active Pharmaceutical Ingredient Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Small Molecule Active Pharmaceutical Ingredient Sales Volume by Countries (2012-2017)
4.4.2 Middle East Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
4.4.4 Israel Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
4.4.5 UAE Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
4.4.6 Iran Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)

5 Africa Small Molecule Active Pharmaceutical Ingredient (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Small Molecule Active Pharmaceutical Ingredient Sales and Value (2012-2017)
5.1.1 Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
5.2 Africa Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Type
5.3 Africa Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Application
5.4 Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume by Countries (2012-2017)
5.4.2 Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Countries (2012-2017)
5.4.3 South Africa Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
5.4.5 Egypt Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)
5.4.6 Algeria Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate (2012-2017)

6 EMEA Small Molecule Active Pharmaceutical Ingredient Manufacturers/Players Profiles and Sales Data
6.1 Johnson Matthey
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Siegfried Holding AG
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi S.A.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novartis AG,
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Boehringer Ingelheim GmbH
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Albany Molecular Research Inc.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Bachem Holding AG
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Small Molecule Active Pharmaceutical Ingredient Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 PCAS
6.12 Patheon N.V.
6.13 AstraZeneca
6.14 Johnson & Johnson
6.15 Merck & Co, Inc.
6.16 BASF SE
6.17 Catalent Inc.
6.18 Teva Pharmaceuticals
6.19 Roche
6.20 Cambrex Corporation?
6.21 GILEAD Science Inc.

7 Small Molecule Active Pharmaceutical Ingredient Manufacturing Cost Analysis
7.1 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Small Molecule Active Pharmaceutical Ingredient Market Forecast (2017-2022)
11.1 EMEA Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Small Molecule Active Pharmaceutical Ingredient Price and Trend Forecast (2017-2022)
11.2 EMEA Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2017-2022)
11.7 EMEA Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Small Molecule Active Pharmaceutical Ingredient
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share by Type (Product Category) in 2016
Figure Standard API Product Picture
Figure High Potency API Product Picture
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Application in 2016
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Respiratory Disorders Examples
Table Key Downstream Customer in Respiratory Disorders
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Market Size (Million USD) by Region (2012-2022)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Status and Forecast by Countries
Figure Africa Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2012-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales Share by Players (2012-2017)
Figure 2016 Small Molecule Active Pharmaceutical Ingredient Sales Share by Players
Figure 2017 Small Molecule Active Pharmaceutical Ingredient Sales Share by Players
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Players (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players (2012-2017)
Table 2016 EMEA Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players
Table 2017 EMEA Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2012-2017)
Figure Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Type (2012-2017)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Small Molecule Active Pharmaceutical Ingredient by Type in 2016
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2012-2017)
Figure Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Application (2012-2017)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2016
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales Share by Region (2012-2017)
Figure Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Region (2012-2017)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Market Share in 2016
Table EMEA Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Small Molecule Active Pharmaceutical Ingredient by Region (2012-2017)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Regions in 2016
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (2012-2017)
Table Europe Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Type (2012-2017)
Table Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Type (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2016
Table Europe Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Application (2012-2017)
Table Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Application (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2016
Table Europe Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Countries (2012-2017)
Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries in 2016
Table Europe Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Countries (2012-2017)
Table Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2012-2017)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2016
Figure Germany Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure France Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure UK Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Type (2012-2017)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Market Share by Type (2012-2017)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Market Share by Type (2012-2017)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Applications (2012-2017)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Market Share by Applications (2012-2017)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2016
Table Middle East Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Sales Volume Market Share by Countries in 2016
Table Middle East Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Countries (2012-2017)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2012-2017)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2012-2017)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2016
Figure Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Type (2012-2017)
Table Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2016
Table Africa Small Molecule Active Pharmaceutical Ingredient Sales (K MT) by Application (2012-2017)
Table Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2012-2017)
Table Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume (K MT) by Countries (2012-2017)
Table Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Countries in 2016
Table Africa Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Countries (2012-2017)
Table Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries (2012-2017)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2016
Figure South Africa Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Pfizer Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Market Share in EMEA (2012-2017)
Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2012-2017)
Table PCAS Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table AstraZeneca Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Merck & Co, Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table BASF SE Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Roche Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Cambrex Corporation? Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Small Molecule Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient
Figure Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Small Molecule Active Pharmaceutical Ingredient Major Manufacturers in 2016
Table Major Buyers of Small Molecule Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Region (2017-2022)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region (2017-2022)
Table Europe Small Molecule Active Pharmaceutical Ingredient Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Countries (2017-2022)
Table Europe Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Small Molecule Active Pharmaceutical Ingredient Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Countries (2017-2022)
Table Africa Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Type (2017-2022)
Table EMEA Small Molecule Active Pharmaceutical Ingredient Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *